Bharat Biotech's Covaxin to cost Rs 600 for states and Rs 1200 for private hospitals
Apr 25, 2021, at 04:38 am
Hyderabad/IBNS: Bharat Biotech's Covaxin will cost Rs 600 for states and Rs 1200 for private hospitals while the exports will cost in the range of $15 to $20, the company said in a statement.
Covaxin neutralises double mutant strain: ICMR
Apr 21, 2021, at 10:52 pm
New Delhi: Covaxin, which is a Made-in-India COVID-19 vaccine, is able to neutralise multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, claimed the Indian Council of Medical Research (ICMR) on Wednesday.
Apr 17, 2021, at 05:55 am
New Delhi/IBNS: Amid the steep rise in Covid-19 cases, the Centre on Friday said it is taking steps to increase and accelerate the production of indigenous vaccines under Atma Nirbhar Bharat 3.0 Mission COVID Suraksha.
India approves Russia’s Sputnik V Covid vaccine: Reports
Apr 12, 2021, at 10:06 pm
New Delhi/UNI: A Subject Expert Committee (SEC) of central government on Monday gave its nod for the emergency use authorization of the Russia's COVID-19 vaccine SPUTNIK V, sources said.
Brazil denies permission to import Bharat Biotech developed Covaxin
Apr 01, 2021, at 04:41 am
New Delhi/IBNS: Brazil's health regulator has denied permission to import Covaxin, the coronavirus vaccine developed by India's indigenous firm Bharat Biotech.
Paraguay receives 100,000 doses of India's Covaxin: Health Ministry
Mar 30, 2021, at 02:33 pm
Buenos Aires/UNI: Paraguay on Monday received the shipment of 100,000 doses of India's first domestically-produced COVID-19 vaccine Covaxin, the country's Health Ministry said.
Nepal approves emergency use of India's COVID-19 vaccine COVAXIN
Mar 22, 2021, at 04:23 am
Kathmandu: Nepal has approved India's COVAXIN COVID-19 vaccine for emergency use, media reports said.
Covaxin taken off clinical trial mode, no consent forms required
Mar 12, 2021, at 03:38 am
New Delhi/IBNS: Pharmaceutical company Bharat Biotech's indigenous Coronavirus vaccine-Covaxin-has been taken off the clinical trial mode, which means beneficiaries will not have to sign consent forms before taking the drug.
COVAXIN is 81 pct effective: Bharat Biotech
Mar 04, 2021, at 12:11 am
Hyderabad: Bharat Biotech, a global leader in vaccine innovation,developing vaccines for infectious diseases, today announced the first interim analysis of itsBBV152 (COVAXIN) where it showed it was 81 percent effective.
India begins second phase of COVID vaccination today: Check out the procedures
Mar 01, 2021, at 11:36 pm
New Delhi: In its fight against COVID-19, India started its second phase of vaccination from Monday.
Delhi resident doctors prefer Covishield over indigenous Covaxin in Covid-19 vaccination drive
Jan 17, 2021, at 01:28 am
New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.
Covid-19 vaccination drive starts in Assam
Jan 16, 2021, at 05:44 pm
Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.
PM Modi launches world's biggest Covid-19 vaccination drive in India
Jan 16, 2021, at 04:25 pm
New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.
PM Modi to launch pan India Covid-19 vaccination drive at 10:30 AM on Saturday
Jan 15, 2021, at 01:35 am
New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing.
PM Modi likely to inaugurate Coronavirus vaccination drive virtually on Jan 16
Jan 14, 2021, at 03:51 am
New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.
Congress MP Manish Tewari questions roll out of Covaxin
Jan 14, 2021, at 01:29 am
New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.
Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin
Jan 13, 2021, at 05:40 pm
Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.
Covid vaccine recipients don't get to choose between two options for now: Centre
Jan 13, 2021, at 03:57 am
New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.
Bharat Biotech announces completion of phase 3 clinical trials of Covid-19 vaccine
Jan 08, 2021, at 12:03 am
New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.
Covid vaccines to rollout within 10 days from date of authorisation: Centre
Jan 06, 2021, at 03:38 am
New Delhi/IBNS: The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.
Jan 05, 2021, at 03:37 am
New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'
India registers 18,177 new Covid-19 cases in last 24 hours, 217 deaths
Jan 03, 2021, at 06:46 pm
New Delhi/IBNS: India registered 18,177 fresh infections in the last 24 hours taking the total Coronavirus cases to 1,03,23,965 on Sunday, the Union Health Ministry data showed.
Serum Institute, Bharat Biotech get DCGI approval for emergency use of Covid-19 vaccines
Jan 03, 2021, at 05:58 pm
New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.
Two Covid-19 vaccine candidates await DCGI approval for emergency use in India
Jan 03, 2021, at 04:24 pm
New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.
Expert panel recommends approval for Bharat Biotech's Covaxin
Jan 03, 2021, at 06:10 am
New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).
Govt's expert panel clears Oxford COVID-19 vaccine for India
Jan 02, 2021, at 03:56 am
New Delhi/IBNS: A government-appointed panel of experts on Friday cleared the Oxford COVID-19 vaccine manufactured by the Serum Institute of India, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).
Govt's expert panel to meet over Covid-19 vaccine approval today
Jan 01, 2021, at 04:30 pm
New Delhi/IBNS: An expert panel, appointed by the central government, will on Friday meet over the approval for an emergency use of three Covid-19 vaccines, including an indigenous one.
After Pfizer and Serum Institute, Bharat Biotech seeks DCGI approval for emergency use of Covaxin
Dec 08, 2020, at 04:41 am
New Delhi/IBNS: After Pfizer and Serum Institute, Hyderabad-based pharmaceutical company Bharat Biotech has sought approval from the Drug Controller General of India (DCGI) for the emergency use authorisation (EUA) of its Covid-19 vaccine-Covaxin, media reports said.
West Bengal Guv Jagdeep Dhankhar inaugurates phase 3 trial of Covaxin in Kolkata
Dec 02, 2020, at 06:19 pm
Kolkata/IBNS: West Bengal Governor Jagdeep Dhankhar on Wednesday inaugurated the third phase trial of India's indigenous vaccine candidate against Covid-19, Covaxin.
Fight against COVID-19: Third phase of human trial of Covaxin to commence soon in IMS- SUM Hospital
Oct 27, 2020, at 07:59 pm
Bhubaneswar/UNI: The third phase of the human trial of COVAXIN, the much-awaited indigenous vaccine being developed against Covid-19, will commence at the Institute of Medical Sciences and SUM Hospital here soon.